Canonical and noncanonical Wnt pathway: A comparison among normal ovary, benign ovarian tumor and ovarian cancer

  • Authors: Levon Badiglian Filho, Celina Tizuko Fujiyama Oshima, Flávio De Oliveira Lima, Henrique De Oliveira Costa, Robério De Sousa Damião, Thiago Simão Gomes, Wagner José Gonçalves
  • View Affiliations

  • Published online on: Sunday, February 1, 2009
  • Pages: 313-320
  • DOI: 10.3892/or_00000223

Abstract

The Wnt family is involved in tumorigenesis of several tissues. In ovarian cancer, the role played by Wnts and its pathways is not clearly defined. In order to analyze the canonical and noncanonical Wnt pathway in normal ovary, benign ovarian tumor and ovarian cancer, we evaluated the immunohistochemical expression of Wnt1, Frizzled-1 (FZD1), Wnt5a, Frizzled-5 (FZD5) and β-catenin. Ovarian specimens were obtained from surgeries performed between 1993 and 2004. The patients were divided in three groups: group A, epithelial ovarian cancer (n=38); group B, benign epithelial neoplasia (n=28); and group C, normal ovaries (n=26). Immunoreactivity for Wnt1, FZD1, Wnt5a, FZD5 and β-catenin was scored for each group. The proportion of Wnt1 positive women in group A (29.4%) was significantly higher than in group B (4.3%) and C (9.1%) (p=0.020). The proportion of FZD1 positive patients in group C (54.5%) was significantly lower than in group A (97.1%) and B (90.0%) (p<0.001). The proportion of Wnt5a positive women was significantly higher for group A (80.0%) compared to group B (25.0%) and C (27.3%) (p<0.001). The proportion of β-catenin positive patients in group C (95.8%) was significantly higher than group B (52.4%) (p=0.004). Comparison of the survival curves in group A according to Wnt5a expression showed a significant difference between positive and negative patients, whereas the Wnt5a positive women showed worse results (p=0.050). Our findings suggest that the pathways related to Wnt5a have an important role in ovarian malignant neoplasia. Furthermore, Wnt5a was found to be a predictor of poor prognosis for ovarian cancer.
Journal Cover

February 2009
Volume 21 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

2013 Impact Factor: 2.191
Ranked #33/202 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Badiglian Filho, L., Oshima, C., De Oliveira Lima, F., De Oliveira Costa, H., De Sousa Damião, R., Gomes, T., & Gonçalves, W. (2009). Canonical and noncanonical Wnt pathway: A comparison among normal ovary, benign ovarian tumor and ovarian cancer. Oncology Reports, 21(2), 313-320.
MLA
Badiglian Filho, Oshima, De Oliveira Lima, De Oliveira Costa, De Sousa Damião, Gomes, and Wagner Gonçalves. "Canonical and noncanonical Wnt pathway: A comparison among normal ovary, benign ovarian tumor and ovarian cancer." Oncology Reports Oncology Reports 21.2 (2009): 313-320.
Chicago
Badiglian Filho, Oshima, De Oliveira Lima, De Oliveira Costa, De Sousa Damião, Gomes, and Wagner Gonçalves. "Canonical and noncanonical Wnt pathway: A comparison among normal ovary, benign ovarian tumor and ovarian cancer." Oncology Reports Oncology Reports 21 no. 2 (2009): 313-320.